99
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Determining the Capability of a Drug Product to Be Terminally Sterilized: A Case Study Involving a Heat-Sensitive, Oxygen-Sensitive Drug Product

, &
Pages 527-534 | Received 03 Sep 1997, Accepted 25 Mar 1998, Published online: 27 Sep 2008

References

  • Use of aseptic processing and terminal sterilization in the preparation of sterile pharmaceuticals for human and veterinary use. Fed. Regist. 1991; 56(198)51354–51358, Code of Federal Regulations, Parts 211, 314, and 514, Title 21 1991
  • Aseptic Fill Conference Transcripts. FDA Formal Meeting October 12–13, 1993; 1–1, through 1–85 and 11–1 through 11–38
  • Guidance for Submission of Documentation for Sterilization Process Validation in Applications for Human and Veterinary Products. Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine. CVM, November, 1994
  • Guideline for Submitting Documentation for Stability of Human Drugs and Biologics. CDER and CBER. 1978
  • Moldenhauer J. D., Rubio S. L., Pflug I. J. Heat resistance of Bacillus Coagulens spores suspended in various parenteral solutions. PDA J. Pharm. Sci. Technol. 1995; 49(5)235–238

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.